Sequencing a person’s genetic code is advancing, promising better detection and earlier diagnoses. Newborn screening in the UK is expanding from 9 treatable conditions to a ‘pilot’ covering 200+. The predictive power of genetic findings is often weaker than many assume; many babies need years of investigations before their risk can be clarified. In this talk, Anneke Lucassen (Professor of Genomic Medicine) will ask whether attempts to end ‘diagnostic odysseys’ that many babies with rare diseases face may lead to ‘predictive odysseys’ for many more.
This event is part of our Tuesday Talks series and is open to Reuben members and their guests. Registration details are noted in our Termcard and weekly college newsletters.
Missed out?
You can read the blog post about this event here.
